EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Cholinergic dysfunction in Alzheimer's disease: Mechanistic perspectives and multi-target effects of traditional Chinese medicine

Yixin Wang, Hongxing Li, Lin Hao, Pai Guo, Bingyan Xu, Meng Cai, Shuo Li

BioScience Trends · 31.10.2026 · 20 (5) · 508-527

DOI: 10.5582/bst.2026.01106 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioScience Trends, erschienen am 31.10.2026. Verfasst von Yixin Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Hebei University, Baoding, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Medicine, Chinese Traditional, Drugs, Chinese Herbal. Die Arbeit nennt 93 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder characterized by progressive cognitive decline and complex pathological changes. Cholinergic dysfunction is an early, clinically pivotal feature of AD closely associated with multiple pathological processes, including amyloid-β (Aβ) pathology, neuroinflammatory responses, mitochondrial dysfunction, metal-ion dyshomeostasis, and apolipoprotein E (APOE) ε4-related vulnerability. While disrupted cholinergic signaling impairs memory formation and synaptic function, its bidirectional interaction with AD-related pathological cascades further accelerates disease progression. Traditional Chinese medicine (TCM) has been investigated as a potential multitarget approach with which to modulate cholinergic deficits and related pathological processes. Some TCM-derived compounds, standardized extracts, and formulas have been reported to regulate cholinergic enzymes, acetylcholine levels, cholinergic receptors, oxidative stress, mitochondrial function, neuroinflammatory responses, and Aβ- or tau-related pathology. This review summarizes the role of cholinergic failure in AD pathophysiology and evaluates the evidence surrounding TCM-based interventions, with emphasis on direct cholinergic evidence, indirect collateral mechanisms, and current translational limitations. Indeed, the purpose of these insights is to inform future development of multitarget therapeutic strategies for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMedicine, Chinese TraditionalDrugs, Chinese HerbalHumansAnimalsAmyloid beta-PeptidesAcetylcholineReceptors, CholinergicOxidative Stress

Stichwörter der Autor:innen

Alzheimer's diseasecholinergic systemmulti-target therapytraditional Chinese medicine

Substanzen

Drugs, Chinese HerbalAmyloid beta-PeptidesAcetylcholineReceptors, Cholinergic

Autor:innen und Institutionen

  • College of Traditional Chinese Medicine, Hebei University, Baoding, China.
  • Department of Pharmacy, Affiliated Hospital of Hebei University, Baoding, China.

Zitieren

APA

Wang, Y., Li, H., Hao, L., Guo, P., Xu, B., Cai, M., & Li, S. (2026). Cholinergic dysfunction in Alzheimer's disease: Mechanistic perspectives and multi-target effects of traditional Chinese medicine. BioScience Trends, 20(5), 508-527. https://doi.org/10.5582/bst.2026.01106

Vancouver

Wang Y, Li H, Hao L, Guo P, Xu B, Cai M, et al. Cholinergic dysfunction in Alzheimer's disease: Mechanistic perspectives and multi-target effects of traditional Chinese medicine. BioScience Trends. 2026;20(5):508-527. doi:10.5582/bst.2026.01106

BibTeX
@article{Wang2026,
  author = {Wang, Yixin and Li, Hongxing and Hao, Lin and Guo, Pai and Xu, Bingyan and Cai, Meng and Li, Shuo},
  title = {Cholinergic dysfunction in Alzheimer's disease: Mechanistic perspectives and multi-target effects of traditional Chinese medicine},
  journal = {BioScience Trends},
  year = {2026},
  volume = {20},
  number = {5},
  pages = {508--527},
  doi = {10.5582/bst.2026.01106}
}
Kostenlos starten →